Table 1. Immunohistochemical findings for lung squamous cell carcinoma and lung adenocarcinoma.
Marker | Lung squamous cell carcinoma | Lung adenocarcinoma | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number of positive cases (%) | Immunoreactivity score† | Number of positive cases (%) | Immunoreactivity score† | ||||||||
0 | 1+ | 2+ | 3+ | 0 | 1+ | 2+ | 3+ | ||||
Glypican-1 | 63/63 (100%) | 0 | 0 | 2 | 61 | 2/60 (3.3%) | 58 | 2 | 0 | 0 | |
p40 | 63/63 (100%) | 0 | 0 | 3 | 60 | 5/60 (8.3%) | 55 | 5 | 0 | 0 | |
CK 5/6 | 62/63 (98.4%) | 1 | 2 | 6 | 54 | 10/60 (16.6%) | 50 | 5 | 4 | 1 | |
TTF-1 | 4/63 (6.3%) | 59 | 3 | 1 | 0 | 54/60 (90.0%) | 6 | 3 | 5 | 46 | |
Napsin A | 2/63 (3.2%) | 61 | 2 | 0 | 0 | 49/60 (81.6%) | 11 | 7 | 3 | 39 |
†, 0: negative; 1+: <10% positive; 2+: 10% to 50% positive; 3+: >50% positive. CK, cytokeratin; TTF-1, thyroid transcription factor-1.